---
title: "PHVS: Oral deucrictibant shows high efficacy and safety for HAE, with launch targeted for April 2024"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299192037.md"
description: "Deucrictibant, an oral therapy for hereditary angioedema, demonstrated strong efficacy and safety in phase III trials, with regulatory reviews progressing in the US and Europe. Commercial launch preparations are on track for 2024, and the pipeline is expanding to address broader bradykinin-mediated disorders.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-09-16T13:31:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299192037.md)
  - [en](https://longbridge.com/en/news/299192037.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299192037.md)
generator: "portal-rs"
---

# PHVS: Oral deucrictibant shows high efficacy and safety for HAE, with launch targeted for April 2024

Deucrictibant, an oral therapy for hereditary angioedema, demonstrated strong efficacy and safety in phase III trials, with regulatory reviews progressing in the US and Europe. Commercial launch preparations are on track for 2024, and the pipeline is expanding to address broader bradykinin-mediated disorders.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [PHVS.US](https://longbridge.com/en/quote/PHVS.US.md)

## Related News & Research

- [Two Pills, One Target: Analyst Bets on Pharvaris as Clinical Risks Fade](https://longbridge.com/en/news/302917214.md)
- [This Allegion Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday](https://longbridge.com/en/news/302873876.md)
- [Oracle Expands AI Software Offerings Ahead of Investor Day](https://longbridge.com/en/news/303115104.md)
- [Alphabet Has $514 Billion in Cloud Orders. Here’s What Matters More Than That Number on Oct. 28.](https://longbridge.com/en/news/303058851.md)
- [Tesla-SpaceX Merger Stands at 80%-90% Chance, Dan Ives' $500 Price Tag Explains Why](https://longbridge.com/en/news/303112286.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**